Key populations brief
Accessed November 2017
Human Rights, Minimum Standards and Monitoring at the European and International Levels
Euro Surveillance 2014;19(47):pii=20970, p.31-37
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines up...date the recommendations that were first released in 2018 on diagnosing, preventing, and managing cryptococcal disease. In response to important new evidence that became available in 2021, these new guidelines strongly recommend a single high dose of liposomal amphotericin B as part of the preferred induction regimen for the treatment of cryptococcal meningitis in people living with HIV. This simplified regimen - a single high dose of liposomal amphotericin B paired with other standard medicines (flucytosine and fluconazole) - is as effective as the previous WHO standard of care, with the benefits of lower toxicity and fewer monitoring demands.
The objective of these guidelines is to provide updated, evidence-informed recommendations for treating adults, adolescents and children living with HIV who have cryptococcal disease. These guidelines are aimed at HIV programme managers, policymakers, national treatment advisory boards, implementing partners and health-care professionals providing care for people living with HIV in resource-limited settings with a high burden of cryptococcal disease.
more
During the implementation of the National Strategic Plan 2009–2012 on HIV and AIDS, Rwanda has continued its progress towards universal access to HIV and AIDS services. The new ...ute-to-highlight medbox">HIV and AIDS National Strategic Plan July 2013–June 2018 (thereafter referred to as ‘the NSP’) presented here is set on pursuing the same objective, with inspiration from the global targets of “zero new HIV infections, zero HIV-related deaths and zero stigma and discrimination due to HIV”.
more
This is an updated introductory two-page document that defines AIDS vaccines and reviews key developments in the field.
16-17 November 2017,
Hotel Djeugua, Yaoundé, Cameroon
Meeting Report December 2017
Published:December 21, 2018
DOI:https://doi.org/10.1016/S2352-3018(18)30289-3
Joint Action for Results
UNAIDS Outcome Framework: Business Case 2009–2011
Regional snapshot: Eastern Europe and Central Asia
December 2018
https://data.unicef.org/wp-content/uploads/2018/11/EECA-regional-snapshot-2018.pdf
Amsterdam, the Netherlands, 23 July 2018
Meeting Report
Meeting report, 25-26 September 2017 Copenhagen, Denmark
Researcher: Sophiko Gogochashvili
Co researchers: Manana Sologashvili, Maka Gogia, Maka Revishvili
Nongovernmental organization "Hepa plus"
2017